Walsh Jeffrey T.

Avg. Two Year Performance

No purchase track record
6% Avg. Sale Return
3% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return(4%)(8%)(12%)8%6%
Sale Success Rate19 of 4615 of 4612 of 4616 of 4610 of 46
Drugs » Biotechnology

Chief Strategy Officer:

Holdings: 40.92K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

($62.00K) Net Amount
Buy:0--
Sell:($62.00K)$124.00